Subcutaneous daratumumab (DARA SC) plus cyclophosphamide, bortezomib, and dexamethasone (CyBorD) in patients (Pts) with newly diagnosed amyloid light chain (AL) amyloidosis: Safety run-in results of andromeda

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 36; no. 15_suppl; p. 8011
Main Authors:	Comenzo, Ray, Kastritis, Efstathios, Maurer, Mathew, Zonder, Jeffrey A., Minnema, Monique, Schönland, Stefan, Wechalekar, Ashutosh, Palladini, Giovanni, Qin, Xiang, Vasey, Sandra Y., Khan, Imran, Schecter, Jordan Mark, Merlini, Giampaolo
Format:	Journal Article
Language:	English
Published:	20-05-2018
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!